Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.
Name:
Targeting the Cohesive Cluster ...
Size:
1.581Mb
Format:
PDF
Description:
Final Published Version
Author
Harryman, William LGard, Jaime M C
Pond, Kelvin W
Simpson, Skyler J
Heppner, Lucas H
Hernandez-Cortes, Daniel
Little, Andrew S
Eschbacher, Jennifer M
Cress, Anne E
Affiliation
Univ Arizona, Canc Ctr, 1515 N Campbell Ave, Tucson, AZ 85724 USAUniv Arizona, Dept Cellular & Mol Med, 1515 N Campbell Ave, Tucson, AZ 85724 USA
Univ Arizona, Coll Med, Med Student Res Program, 1515 N Campbell Ave, Tucson, AZ 85724 USA
Univ Arizona, Canc Biol Res Program, 1515 N Campbell Ave, Tucson, AZ 85724 USA
Issue Date
2017-11-01
Metadata
Show full item recordPublisher
ELSEVIER SCIENCE INCCitation
Harryman WL, Gard JMC, Pond KW, et al. Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy. Neoplasia (New York, NY). 2017;19(11):919-927. doi:10.1016/j.neo.2017.08.005.Journal
NeoplasiaRights
© 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Chordoma is a rare, radiation-resistant, skull-base and spinal tumor with high local recurrence containing mixed cell-adhesion phenotypes. We characterized DNA damage response (DDR) signaling (γH2AX, pKAP1, pATM) and survival response to ionizing radiation (IR) in human chordoma samples (42 resections, 23 patients) to test if blocking cell adhesion sensitizes U-CH1 tumor cells to IR. U-CH1 cells expressed brachyury, YAP, and laminin adhesion receptors (CD49c, CD49f, CD44), and approximately 15% to 20% of U-CH1 cells featured an α6 integrin-dependent (CD49f) cohesive cluster phenotype, which confers therapeutic resistance and aids metastasis. DDR to IR in U-CH1 cells was compared to normal prostate epithelial (PrEC) and tumor cells (DU145). Flow cytometry showed a dose- and time-dependent increase in γH2AX and pKAP1 expression in all cell lines. However, nearly 50% of U-CH1 cells exhibited nonresponsive phenotype to IR (measured by γH2AX and pKAP1) independent of cell cycle status. Immunofluorescence microscopy verified that only 15% of U-CH1 clustered cells were γH2AX or pKAP1 positive (versus 80% of nonclustered cells) 2 hours following 2-Gy IR. Conversely, both tumor cell lines were uniformly defective in pATM response. HYD1, a synthetic ECM ligand, inhibited DDR through an unresolved γH2AX response. β1 integrin-blocking antibody (AIIB2) decreased cell survival 50% itself and approximately doubled the IR-induced cell kill at all IR doses observed at 2 and 4 weeks posttreatment. These results suggest that a heterogeneity of DDR to IR exists within a chordoma population. Blocking integrin function alone and/or as an adjuvant to IR may eradicate chordomas containing the cohesive cluster phenotype.Note
Open access journal.ISSN
1476-5586PubMed ID
28954241Version
Final published versionSponsors
National Institutes Health [P30CA23074, RO1CA159406, T32CA09213, T35HL007479]Additional Links
https://www.neoplasia.com/article/S1476-5586(17)30187-2/abstractae974a485f413a2113503eed53cd6c53
10.1016/j.neo.2017.08.005
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Related articles
- Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
- Authors: Kim JY, Lee J, Koh JS, Park MJ, Chang UK
- Issue date: 2016 Nov
- Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
- Authors: Karikari IO, Gilchrist CL, Jing L, Alcorta DA, Chen J, Richardson WJ, Gabr MA, Bell RD, Kelley MJ, Bagley CA, Setton LA
- Issue date: 2014 Sep
- Chordoma-derived cell line U-CH1-N recapitulates the biological properties of notochordal nucleus pulposus cells.
- Authors: Fujita N, Suzuki S, Watanabe K, Ishii K, Watanabe R, Shimoda M, Takubo K, Tsuji T, Toyama Y, Miyamoto T, Horiuchi K, Nakamura M, Matsumoto M
- Issue date: 2016 Aug
- Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
- Authors: Scheil S, Brüderlein S, Liehr T, Starke H, Herms J, Schulte M, Möller P
- Issue date: 2001 Nov
- Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum: A Systematic Review.
- Authors: Pennicooke B, Laufer I, Sahgal A, Varga PP, Gokaslan ZL, Bilsky MH, Yamada YJ
- Issue date: 2016 Oct 15